TRISENOX blev indgivet intravenøst over 1 til 2 timer, indtil knoglemarven var fri for leukæmiceller, op til maksimalt 60 dage.
TRISENOX was administered intravenously over 1 to 2 hours until the bone marrow was free of leukaemic cells, up to a maximum of 60 days.